Surgical hepatic resection vs. ultrasonographic guided radiofrequency ablation in colorectal liver metastases: what should we choose?
- PMID: 24791846
- DOI: 10.11152/mu.201.3.2066.162.bsu1
Surgical hepatic resection vs. ultrasonographic guided radiofrequency ablation in colorectal liver metastases: what should we choose?
Abstract
Clinical evolution of the colorectal carcinoma occurs in up to 60% with colorectal liver metastases (CRLM). Although hepatic resection is considered to be the golden standard in CRLM, novel less invasive techniques have emerged, of which radiofrequency ablation has received a high credibility. When tumors are not eligible for surgery, guided radiofrequency ablation is considered an alternative. This method is appropriate when there are no more than 5 lesions with a diameter of less than 3 cm. While open surgery guarantees a more precise tumor excision, the effectiveness of ablation must be evaluated either by contrast-enhanced computer tomography, magnetic resonance, or ultrasound. This paper aim to review the current standings in radiofrequency ablation for CRLM and to compare the technique with surgical resection in order to find which one is the best treatment option.
Similar articles
-
Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver metastases.Ultraschall Med. 2008 Aug;29(4):388-92. doi: 10.1055/s-2008-1027197. Ultraschall Med. 2008. PMID: 18785319
-
Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report.Surg Laparosc Endosc Percutan Tech. 2002 Jun;12(3):160-4. doi: 10.1097/00129689-200206000-00004. Surg Laparosc Endosc Percutan Tech. 2002. PMID: 12080255
-
Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.Scand J Surg. 2015 Sep;104(3):169-75. doi: 10.1177/1457496914553147. Epub 2014 Oct 20. Scand J Surg. 2015. PMID: 25332220
-
[Radiofrequency of the liver - an update].Rofo. 2011 Aug;183(8):704-13. doi: 10.1055/s-0029-1246082. Epub 2011 Feb 11. Rofo. 2011. PMID: 21318934 Review. German.
-
Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.Dig Surg. 2008;25(6):445-60. doi: 10.1159/000184736. Epub 2009 Feb 12. Dig Surg. 2008. PMID: 19212117 Review.
Cited by
-
Efficacy of Endobiliary Radiofrequency Ablation in Preserving Survival, Performance Status and Chemotherapy Eligibility of Patients with Unresectable Distal Cholangiocarcinoma: A Case-Control Study.Diagnostics (Basel). 2022 Jul 26;12(8):1804. doi: 10.3390/diagnostics12081804. Diagnostics (Basel). 2022. PMID: 35892515 Free PMC article.
-
In Vivo Experimental Study of an Endoscopic Ultrasound Multifunctional Radiofrequency Ablation Probe.Curr Health Sci J. 2016 Oct-Dec;42(4):359-364. doi: 10.12865/CHSJ.42.04.05. Epub 2016 Feb 28. Curr Health Sci J. 2016. PMID: 30581590 Free PMC article.
-
The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.Medicine (Baltimore). 2016 Sep;95(39):e4999. doi: 10.1097/MD.0000000000004999. Medicine (Baltimore). 2016. PMID: 27684857 Free PMC article.
-
Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence.Curr Treat Options Oncol. 2017 Feb;18(2):8. doi: 10.1007/s11864-017-0452-6. Curr Treat Options Oncol. 2017. PMID: 28214976 Review.
-
The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate.Pharmaceuticals (Basel). 2022 Feb 10;15(2):215. doi: 10.3390/ph15020215. Pharmaceuticals (Basel). 2022. PMID: 35215327 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical